Keywords:
Lymph nodes, Oncology, Mediastinum, CT-Angiography, MR, MR-Diffusion/Perfusion, Chemotherapy, Comparative studies, Diagnostic procedure, Haematologic diseases, Lymphoma
Authors:
A. Mikhaylov, V. Panov, I. E. Tyurin; Moscow/RU
DOI:
10.1594/ecr2013/C-1360
Purpose
The aim of this study is to compare the performance of whole-body MRI including: the diffusion-weighted (DWIBS) and STIR imaging,
and whole body positron emission tomography and computed tomography in patients diagnosed to have lymphoma.
Staging,
dynamic monitoring and evaluation of treatment effectiveness of lymphoproliferative diseases requires accurate assessment of affected lymph nodes and extra nodular lesions.
Exclusion of concomitant pathologies and evaluation of comorbide states may affect on treatment.
Whole-body MRI may be useful in detecting systemic failures due to it’s high relative soft tissues contrast.
MRI can be not limited in number and volume of studies due to it’s harmless to the patient.
Whereas more traditional radiology methods,
such as contrast enhanced CT,
scintigraphy,
PET,
PET-CT are associated with increased radiation exposure and less effective in small focal lesions early detection.
So,
it is actual to hold whole-body MRI in oncological profile patients for early multifocal lesions diagnosis.